CDKN2A and Huntington disease: However, the sensitivity and specificity of immunohistochemical MTAP expression as a surrogate for FISH for CDKN2A HD have not been fully investigated in PeM and, consequently, its reliability as a diagnostic and prognostic biomarker for this neoplasm is still rather controversial.